A deep dive into specific issues and answers to commonly asked questions. This section is regularly updated
Lump sum funding is gradually introduced in several EU funding programmes with the aim to reduce administration and financial errors. Lump sums grants have a budget defined at proposal stage and fixed in the grant agreement.
All basic information you need to find out whether EDF is something for you and how to get started in EDF
An overview of projects that have been selected for funding
The EU Defence Innovation Scheme (EUDIS) is a set of instruments enabled by the European Defence Fund (EDF) to strengthen defence innovation in the European Union.
Participation in the Digital Europe programme is open to eligible third countries, taking into account certain restrictions in specific cases.
The coordinator mostly starts playing his role during project proposal stage and continues beyond its end date. He acts as the central hub of the project, providing leadership, coordination and management to ensure the successful implementation.
To simplify the declaration of costs, unit costs can be used for staff costs and internally invoiced goods and services under Digital Europe
This infosheet provides information on the clinical studies annex that must be attached for calls that involve clinical studies.
This infosheet provides an overview of key elements to take into account for calls that will be evaluated blindly.
This infosheet on two-stage calls provides an overview of key elements to take into account in a two-stage submission procedure.
The Horizon2020 project BEAT-AF brings together 9 European renowned clinical centres in France, Belgium, Czechia, Germany and Austria. Together, the consortium strives to revolutionize Atrial Fibrillation (AF) treatment through catheter ablation and contribute to decrease the huge burden of AF in Europe. The BEAT-AF project kicked off in 2021 and will run until 2026. The department of electrophysiology of the AZ Sint-Jan Hospital in Bruges is partner in the project and has so far contributed to the pre-clinical development, the first in man studies and first registries of the revolutionary AF treatment put forward by the consortium. The first pilot studies show that the treatment is safe, effective and efficient.